Funding for this research was provided by:
This study was funded by Mitsubishi Tanabe Pharma Corporation (Osaka, Japan).
Received: 15 November 2019
Accepted: 19 May 2020
First Online: 29 June 2020
Ethics approval and consent to participate
: All procedures performed in this study involving human participants were in accordance with the ethical standards of our institutional ethical committee (IRB approval number TGE 00388-024) and with the 1964 Helsinki declaration and its later amendments.
: Written informed consent was obtained from all individual participants included in the study.
: We declare that we have no competing interests.